Financial Information
Pharmaceutical Product Development, Inc.
NASD: (PPDI)Sector: Healthcare
Industry: Biotechnology & Drugs
| BRIEF: For the six months ended 30 June 2007, Pharmaceutical Product Development, Inc.'s revenues increased 12 percent to $682.2 million. Net income increased 8 percent to $84.6 million. Revenues reflect an increase in sales from development division and higher sales from reimbursed out-of-pocket sales. Net income was partially offset by an increase in research & development expenses, higher selling, general & administrative expenses and increased depreciation expenses. OFFICERS: Ernest Mario, Chairman of the Board; Fredric Eshelman, Vice Chairman of the Board, Chief Executive Officer; Daniel Darazsdi, Chief Financial Officer; William Sharbaugh, Chief Operating Officer; Paul Covington, Executive Vice President - Development. TRANSFER AGENT: American Stock Transfer Trust Company. Company incorporated in N.C. Direct inquiries to: Director of Investor Relations. |
|
Pharmaceutical Product Development, Inc. 929 North Front Street Wilmington, NC 28401 Phone: +910 558 7585 Fax: +910 558 7056 Sector Name: Healthcare Industry Name: Biotechnology & Drugs Complete Financials: 30 Jun 2007 |
| Latest Earnings Release & 10-Q | Date Filed | Format | Size | |
|---|---|---|---|---|
| Fourth Quarter Financial Results |  |
N/A | ||
| Form 10-Q | Nov 3, 2009 | 
|
571.3 KB | |
| Latest Annual Report & 10-K | Date Filed | Format | Size | |
| Form 10-K | Feb 26, 2010 |
|
2.4 MB | |
| Ticker | PPDI |
| Exchange | NASDAQ | Price | $22.06 |
| Change | - 0.07 |
| Volume | 1,124,400 |
| 3/15/2010 - 3:59 PM ET | |
